Site Maintenance will take place from 4:00 PM on 2024-04-29 to 9:00 AM on 2024-05-01.
Please do not make any content change during this time, otherwise all the changes will be lost.

Select Publications

Journal articles

Ray JD; Day RO, 1984, 'High-performance liquid chromatographic determination of a new anti-inflammatory agent, nabumetone, and its major metabolite in plasma using fluorimetric detection', Journal of Chromatography B: Biomedical Sciences and Applications, 336, pp. 234 - 239, http://dx.doi.org/10.1016/S0378-4347(00)85146-4

Graham GG; Day RO; Champion GD; Lee E; Newton K, 1984, 'Aspects of the clinical pharmacology of non-steroidal anti- inflammatory drugs', Clinics in Rheumatic Diseases, 10, pp. 229 - 249

Day RO; Graham GG; Champion GD; Lee E, 1984, 'Anti-rheumatic drug interactions', Clinics in Rheumatic Diseases, 10, pp. 251 - 275

McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN, 1984, 'Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate', Medical Journal of Australia, 141, pp. 349 - 351, http://dx.doi.org/10.5694/j.1326-5377.1984.tb132803.x

Lee EJD; Williams KM; Graham GG; Day RO; Champion GD, 1984, 'Liquid chromatographic determination and plasma concentration profile of optical isomers of ibuprofen in humans', Journal of Pharmaceutical Sciences, 73, pp. 1542 - 1544, http://dx.doi.org/10.1002/jps.2600731112

DAY RO; HARRIS G; BROWN M; GRAHAM G, 1983, 'ASPIRIN GLUCOCORTICOSTEROID INTERACTION IN MAN', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 717 - 717, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ray JE; Day RO, 1983, 'High‐performance liquid chromatographic analysis of diflunisal in plasma and urine: Application to pharmacokinetic studies in two normal volunteers', Journal of Pharmaceutical Sciences, 72, pp. 1403 - 1405, http://dx.doi.org/10.1002/jps.2600721209

Day RO; Shen DD; Azarnoff DL, 1983, 'Induction of Salicyluric Acid Formation in Rheumatoid Arthritis Patients Treated with Salicylates', Clinical Pharmacokinetics, 8, pp. 263 - 271, http://dx.doi.org/10.2165/00003088-198308030-00005

BEGG EJ; CHINWAH PM; WEBB C; DAY RO; WADE DN, 1983, 'INTERACTION OF MEXILETINE WITH PHENYTOIN', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 191 - 192, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983QN17900029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

RAY JE; REILLY DK; HAAVISTO T; PAULL PD; DAY RO, 1983, 'SURVEY OF DRUG-ABUSE PATTERNS IN A CASUALTY DEPARTMENT POPULATION', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 715 - 716, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sambrook PN; Browne CD; Champion GD; Day RO; Vallance JB; Warwick N, 1982, 'Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis', Journal of Rheumatology, 9, pp. 932 - 934

Day RO; Sambrook P; Champion GD; Graham GG, 1982, 'Antimalarials in rheumatic diseases', Australian and New Zealand Journal of Medicine, 12, pp. 645 - 649, http://dx.doi.org/10.1111/j.1445-5994.1982.tb02658.x

Champion GD; Bieri D; Browne CD, 1982, 'Auranofin in rheumatoid arthritis', Journal of Rheumatology, 9, pp. 137 - 145

DAY RO; FURST DE; DROMGOOLE SH; PAULUS HE, 1982, 'DECLINE OF STEADY-STATE SERUM SALICYLIC-ACID CONCENTRATIONS WITH TIME IN NORMAL VOLUNTEERS GIVEN HIGH-DOSE ASPIRIN', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 557 - 558, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

RAY JE; DAY RO, 1982, 'DIFLUNISAL, A SPECIFIC ANALYTICAL PROCEDURE AND PRELIMINARY PHARMACOKINETICS IN MAN', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 572 - 572, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ray JE; Day RO, 1982, 'Diflunisal, a specific analytical procedure and preliminary pharmacokinetics in man', Clinical and Experimental Pharmacology and Physiology, 9, pp. 453

Begg E; Chinwah P; Webb C; Day R; Wade D, 1982, 'Enhanced metabolism of mexiletine after phenytoin administration.', British Journal of Clinical Pharmacology, 14, pp. 219 - 223, http://dx.doi.org/10.1111/j.1365-2125.1982.tb01965.x

Day RO; Furst DE; Dromgoole SH; Kamm B; Roe R; Paulus HE, 1982, 'Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 31, pp. 733 - 740, http://dx.doi.org/10.1038/clpt.1982.103

HARRIS G; CAIRNS D; BIERI D; CHAMPION D; DAY R; GRAHAM G, 1982, 'RESPONSE OF RHEUMATOID-ARTHRITIS TO SLOWLY ACTING ANTI-RHEUMATIC DRUGS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 561 - 561, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Day RO; Pearson CM, 1981, 'Primary inflammatory muscle diseases', Comprehensive Therapy, 7, pp. 22 - 30

Day RO; Furst DE; Dromgoole SH, 1981, 'Decline in steady-state serum levels of salicylate in normal subjects: Preliminary results', Clinical and Experimental Pharmacology and Physiology, 8

Day RO, 1981, 'Effects of exercise performance on drugs used musculoskeletal disorders', Medicine and Science in Sports and Exercise, 13, pp. 272 - 275, http://dx.doi.org/10.1249/00005768-198104000-00013

Day RO; Dromgoole SH; Furst DE; Hignite C; Paulus HE, 1981, 'Formation of methyl ester of salicyluric acid during quantitation of salicyluric acid in urine by high‐pressure liquid chromatography', Journal of Pharmaceutical Sciences, 70, pp. 1090 - 1092, http://dx.doi.org/10.1002/jps.2600700934

Day RO; Furst DE; Dromgoole SH, 1981, 'Naproxen serum level response relationship in rheumatoid arthritis', Australian and New Zealand Journal of Medicine, 11, pp. 720

Furst DE; Day RO; Dromgoole SH, 1981, 'Steady-state serum level vs response relationship for naproxen in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 29, pp. 247

Day RO; Lindsley HB, 1979, 'Rational use of aspirin and nonsteroidal anti-inflammatory drugs in inflammatory arthritis.', The Journal of the Kansas Medical Society, 80, pp. 155 - 159

Champion GD; Day RO; Paull PD, 1979, 'Clinical pharmacology and efficacy of benorylate in patients with rheumatoid arthritis', Current Therapeutics, 20, pp. 145

Day RO, 1979, 'DEAFNESS DUE TO ASPIRIN', The Journal of Clinical Pharmacology, 19, pp. 328 - 328, http://dx.doi.org/10.1002/j.1552-4604.1979.tb02488.x

Day R; Shen D; Azarnoff D, 1979, 'Decline of steady-state serum salicylate in rheumatoid arthritics given high-dosage salicylate therapy', Clinical Pharmacology and Therapeutics, 25, pp. 220 - 221

Day RO; Shen DD; Azarnoff DL, 1979, 'Effect of high-dosage salicylate therapy on average steady-state serum salicylate and formation of salicylurate in patients with rheumatoid arthritis', Clinical Research, 27

RAY JE; WADE DN; GRAHAM GG; DAY RO, 1979, 'Pharmacokinetics of Carprofen in Plasma and Synovial Fluid', The Journal of Clinical Pharmacology, 19, pp. 635 - 643, http://dx.doi.org/10.1002/j.1552-4604.1979.tb01626.x

Graham G; Champion GD; Day RO, 1979, 'The pharmacokinetics of salicyclate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 6, pp. 194

Day RO; Wade DN, 1978, 'Influence of flufenamic acid and calcium ion concentration on the histamine release from rat mast cells induced by compound 48/80 and the calcium ionophore A23187', Biochemical Pharmacology, 27, pp. 1385 - 1387, http://dx.doi.org/10.1016/0006-2952(78)90126-0

Champion GD; Day RO; Paull PD; Graham GG; Owen MS; Haski AL; Hills L, 1978, 'Clinical Pharmacology and Efficacy of Benorylate in Patients with Rheumatoid Arthritis', Australian and New Zealand Journal of Medicine, 8, pp. 22 - 28, http://dx.doi.org/10.1111/j.1445-5994.1978.tb02398.x

Day RO; Wade DN, 1978, 'EFFECTS OF VARIOUS DRUGS ON THE OSMOTIC LYSIS OF RAT MAST CELLS', Clinical and Experimental Pharmacology and Physiology, 5, pp. 477 - 485, http://dx.doi.org/10.1111/j.1440-1681.1978.tb00700.x

Day RO; Wade DN, 1978, 'THE EFFECT OF VARIOUS DRUGS ON ADENOSINE TRIPHOSPHATE CONTENT AND HISTAMINE RELEASE FROM RAT PERITONEAL CELL SUSPENSIONS RICH IN MAST CELLS', Clinical and Experimental Pharmacology and Physiology, 5, pp. 223 - 227, http://dx.doi.org/10.1111/j.1440-1681.1978.tb00675.x

Day RO; Champion GD; Wade DN, 1978, 'The effect of various drugs on compound 48/80 and osmotic shock-induced histamine release from rat peritoneal cells', Clinical and Experimental Pharmacology and Physiology, 5, pp. 241 - 242

Bowden GJ; Day RK, 1977, 'A novel low temperature rearrangement of atoms in the rare earth intermetallic compound ErFe3', Journal of Physics F: Metal Physics, 7, pp. 181 - 190, http://dx.doi.org/10.1088/0305-4608/7/1/027

Bowden GJ; Day RK, 1977, 'On the magnetic anomaly in ErFe3 at 47K', Journal of Physics F: Metal Physics, 7, pp. 191 - 197, http://dx.doi.org/10.1088/0305-4608/7/1/028

Graham GG; Champion GD; Day RO; Kaski AL; Hills LG; Paull PD, 1977, 'Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic response.', Agents and Actions Supplements, pp. 37 - 42

Day RO; Paull PD; Ray JE; Wade DN, 1977, 'The measurement of histamine release from suspensions of rat peritoneal cells rich in mast cells', Agents and Actions, 7, pp. 431 - 436, http://dx.doi.org/10.1007/BF01966848

Day RK; Bowden GJ, 1977, 'Magnetic anomalies in ErFe3', Physica B+C, 86-88, pp. 71 - 72, http://dx.doi.org/10.1016/0378-4363(77)90230-3

Graham GG; Champion GD; Day RO; Paull PD, 1977, 'Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 22, pp. 410 - 420, http://dx.doi.org/10.1002/cpt1977224410

Grahm GG; Champion GD; Day RO, 1977, 'Salicylates in rheumatoid arthritis: Pharmacokinetics and analgesic responses', Agents and Actions, 7, pp. 35 - 42

Champion GD; Day RO; Fagan N, 1977, 'Single dose comparison of analgesic action of acetylsalicylate and sodium salicylate in rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 4, pp. 213

Champion GD; Corrigan AB; Day RO, 1977, 'The effect of enteric coating of aspirin tablets on occult gastrointestinal blood loss', Clinical and Experimental Pharmacology and Physiology, 4, pp. 214 - 215

Day RO; Ray JE; Champion GD; Wade DN, 1977, 'The effect of non steroidal anti inflammatory drugs on ATP levels and histamine release from rat peritoneal cell suspension rich in mast cells', Clinical and Experimental Pharmacology and Physiology, 4, pp. 212 - 213

CHAMPION GD; DAY RO; RAY JE; WADE DN, 1977, 'THE EFFECT OF NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS ON ADENOSINE TRIPHOSPHATE CONTENT AND HISTAMINE RELEASE FROM RAT PERITONEAL CELL SUSPENSIONS RICH IN MAST CELLS', British Journal of Pharmacology, 59, pp. 29 - 33, http://dx.doi.org/10.1111/j.1476-5381.1977.tb06973.x

Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG, 1977, 'The Effects of Enteric Coating of Aspirin Tablets on Occult Gastrointestinal Blood Loss', Australian and New Zealand Journal of Medicine, 7, pp. 600 - 604, http://dx.doi.org/10.1111/j.1445-5994.1977.tb02315.x

Graham G; Champion GD; Day RO; Paull PD, 1977, 'The pharmacokinetics of salicylate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 4, pp. 214


Back to profile page